Joshua Pinto insider trades

Open-market stock purchases and sales by Joshua Pinto, President & CEO at Neumora Therapeutics, Inc, from SEC Form 4 filings since Feb 14, 2024.

Recent trades

DateStockTradeValue
Aug 20, 2026NMRA Neumora Therapeutics, IncBought (not open market)—
Feb 17, 2026NMRA Neumora Therapeutics, IncSold$21.1K
Jan 8, 2026NMRA Neumora Therapeutics, IncBought (not open market)—
Nov 13, 2025MTSR Metsera, IncSold (not open market)—
Nov 13, 2025MTSR Metsera, IncBought (not open market)—
Nov 13, 2025MTSR Metsera, IncSold (not open market)$472K
Nov 13, 2025MTSR Metsera, IncSold (not open market)$645K

Companies traded

  • NMRA Neumora Therapeutics, Inc: 6 sales, last Aug 20, 2026
  • MTSR Metsera, Inc: other filings, last Nov 13, 2025

Get free alerts when Joshua Pinto files a new trade →